A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/A:1005891506092
Reference53 articles.
1. Osborne CK: Receptors. In: Harris J, Hellman S, Henderson I et al. (eds) Breast Diseases. Philadelphia, JB Lippincott, 301–325, 1991
2. Early breast cancer trialists collaborative group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339: 71–85, 1992
3. Goldhirsch A, Wood WC, Senn H-J, Glick JH, Gelber RD: Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 87: 1441–1445, 1995
4. Love RR: Prospects for antiestrogen chemoprevention of breast cancer. J Natl Cancer Inst 82: 18–22, 1990
5. Powles TJ, Hardy JK, Ashley SE, Farrington GM, Cosgrove D, Davey JB, Dowsett M, McKinna JA, Nash AG, Sinnet HD, Tillyer CR, Treleaven JG: A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for preventing brest cancer. Br J Cancer 60: 126–131, 1990
Cited by 74 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Breast Cancer Treatments: Updates and New Challenges;Journal of Personalized Medicine;2021-08-19
2. Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2;Journal of Proteome Research;2020-09-10
3. Current understanding of selective estrogen receptor modulators;Journal of obstetrics and women's diseases;2020-02-19
4. Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators;Climacteric;2019-03-04
5. Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment;Pharmacology & Therapeutics;2018-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3